Cite

HARVARD Citation

    Leader, R. et al. (2020). Republished: Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis. Drug and therapeutics bulletin. 58 (4), pp. 60-63. [Online]. 
  
Back to record